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Background/aim: The Aegean Region is the second-ranking region in Turkey according to the Human Development Index and
population density and it hosts 1/8 of Turkey’s population. İzmir is the largest city of the region, receiving internal migration both
from inside and outside the region. The tuberculosis incidence in İzmir is lower than overall in Turkey: 17.7/100,000 in 2011. Our aims
were to determine genotypes of Mycobacterium tuberculosis isolates; to explore possible associations between genotypes with casedemographic data, clinical presentation, and antimicrobial susceptibility patterns; and to determine variations in genotype distribution
of strains isolated in Ege University Hospital, İzmir.
Materials and methods: Forty-nine M. tuberculosis isolates from 49 patients in 1996–2000 and 421 M. tuberculosis isolates from 421
patients in 2009–2014 were spoligotyped. Drug susceptibility testing and demographic data of the 421 isolates were investigated. Chisquare, Student’s t, and Mann–Whitney U tests were used for analyses.
Results: Among the 470 M. tuberculosis strains, 132 different spoligopatterns were identified and 46 different clusters for 384 strains
were determined. The most predominant spoligotypes were ST53 (n = 116; 24.7%) and ST41 (n = 38; 8.1%), followed by ST50 (5.7%),
ST284 (4.7%), and ST4 (4.3%), respectively. ST53 was the most predominant type in both sexes. Multidrug resistance (MDR) was
determined in 12 isolates, of which six were ST1.
Conclusion: As a consequence of worldwide migration and increasing status of HIV-infected hosts, the increasing prevalence of Beijing
strains with higher MDR rates may threaten disease control programs. With its increasing trend, ST284 could replace ST41 in the
following years in this region.
Key words: Spoligotyping, Mycobacterium tuberculosis, genetic diversity, tuberculosis epidemiology

1. Introduction
According to World Health Organization data, although
there is a decreasing trend in tuberculosis (TB) incidence,
prevalence, and mortality worldwide, the number of new
TB cases in 2014 was estimated as 9.6 million, including 5.4
million men, 3.2 million women, and 1 million children.
In 2014, 1.5 million individuals died because of TB (1).
The incidence of TB in Turkey has dropped from
52.2/100,000 in 1980 to 26/100,000 in 2005 and 18/100,000
in 2014 (1–3). In total, 15,679 new TB cases, consisting of
59% pulmonary, 37% extrapulmonary, and 4% simultaneous
pulmonary and extrapulmonary TB cases, were reported in
Turkey in 2011. Among these cases, 59% of patients were
males and 41% were females, and the highest incidence rates
for both sexes were over the age of 65 years (2).
* Correspondence: fetferday@gmail.com

The Aegean Region is the second-ranking region in
Turkey according to the Human Development Index and
population density and it hosts 1/8 of Turkey’s population.
İzmir is the largest city of the region and Turkey’s third
largest city with its 4,113,000 inhabitants receiving internal
migration both from inside and outside the region (4,5).
TB incidence in İzmir is lower than overall in Turkey:
17.7/100,000 in 2011. In İzmir, a total of 700 cases were
reported in 2011 and 61% of the cases were pulmonary,
33% extrapulmonary, and 6% both pulmonary and
extrapulmonary. Among the patients, 64% were male and
36% were female (2).
The aims of this study were to determine the genotypes
of Mycobacterium tuberculosis strains isolated in Ege
University Medical School’s hospital in 2009–2014; to
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explore the possible associations between genotypes
and case-demographic data, clinical presentation, and
antimicrobial susceptibility patterns; and to determine
variations in genotype distributions of the strains.
2. Materials and methods
2.1. M. tuberculosis isolates
All of the M. tuberculosis strains, which were isolated by
automated liquid culture system in the hospital of the Ege
University Medical School between 2009 and 2014, were
included in the study. In order to detect a possible shift in
the distribution of M. tuberculosis strains throughout the
years, 49 strains isolated between 1996 and 1998 were also
spoligotyped.
The 421 M. tuberculosis strains isolated in 2009–2014
constitute 10%, 5%, and 0.5% of all the strains isolated in
İzmir, in the Aegean Region, and in Turkey, respectively,
in the same period (2). Among the 421 strains studied,
268 (63.9%) were isolated from pulmonary TB and
131 (31.3%) from extrapulmonary TB patients’ clinical
samples, while 20 (4.8%) patients had both pulmonary
and extrapulmonary TB, and the remaining two isolates’
locations were undefined.
2.2. Demographic data
Demographic data of the 421 patients in the 2009–
2014 period were obtained from the Ege University
Medical School’s Medical Microbiology Department’s
Mycobacteriology Laboratory records and the hospital’s
database. It was not possible to reach these data for the
1996–1998 period so this period was excluded from the
demographic analyses.
2.3. Spoligotyping
A standard spoligotyping procedure was applied according
to the manufacturer’s instructions (Isogen Life Science
Spoligotyping Kit, the Netherlands) (6). All spacers in
the direct repeat (DR) region were amplified with PCR
using DRa (biotin-labeled) and DRb primers. The biotinlabeled amplified spacers were hybridized with different
spacer probes that covalently bond to the membrane.
The spacers hybridized on the membrane were incubated
with HRP-conjugate and substrate. The membrane was
treated with X-ray or visualized by Fusion FX7 (Vilber
Lourmat, France) chemiluminescence imaging systems
to detect hybridized spacers. The presence of a hybridized
spacer was considered as a positive signal while the lack of
spacer hybridization was considered as a negative signal.
The binary spoligotype values obtained for each strain
were entered into the database located at http://www.
pasteur-guadeloupe.fr/tb/bd_myco.html, and the Spoligo
International Type (SIT) number and the family that it
belongs to were determined.
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2.4. Drug susceptibility testing (DST)
DST was performed during routine laboratory procedures.
Susceptibility to rifampicin (RIF), isoniazid (INH),
ethambutol, and streptomycin was determined by the agar
proportional method or with the MGIT960 automated
system (BD, USA) (7).
2.5. Data analysis
Two or more patient isolates with the same spoligopattern
were considered as a cluster. Epidemiologic and clinical
data of the strains were compared with the chi-square
test or Fisher’s exact test. The most frequent eight types
(total n > 10) were further analyzed according to sex,
age, and place of birth by creating dichotomous variables
encoded as the specific type of interest versus the total of
others, comprising orphans. Trends in consecutive age
groups and in study years grouped into four consecutive
groups (1996–98, 2009–10, 2011–12, 2013–14) and were
tested with chi-square tests for trend analysis. Statistical
significance was set at P < 0.05 (CI: 95%).
3. Results
3.1. M. tuberculosis spoligotypes and their distribution in
different study years
Among the 470 M. tuberculosis strains, 132 different
spoligopatterns were determined, 384 strains formed
46 clusters, and the clustering rate was 81.7%. The most
dominant spoligotype was ST53 (n = 116; 24.7%), followed
by ST41 (LAM7-TUR), ST50, ST284, and ST4. Among M.
tuberculosis strains, 54 of them had no corresponding SIT
in the database. The most dominant spoligotype was the
T family (n = 219; 46.6%), followed by Haarlem (n = 75;
16%), LAM (n = 58; 12.3%), unknown (n = 30; 6.4%), S (n
= 14; 3%), Beijing (n = 11; 2.3%), CAS (n = 4; 0.9%), and X
(n = 4; 0.9%) families. There was no M. tuberculosis strain
belonging to the EAI family. ST41 was found in 18.4% and
ST4 in 8.2% of the strains isolated in 1996–1998 while
their rates were 6.9% and 3.6%, respectively, in 2009–2014.
Conversely, ST284 and ST1 (Beijing) were not detected
among the strains isolated in 1996–1998 but they were
detected in 5.2% and 2.6% of the strains in 2009–2014
(Table 1).
A significantly decreasing trend was observed for
ST41, with rates of 18.4%, 8.7%, 7.4%, and 4.0% isolated
in 1996–98, 2009–10, 2011–12, and 2013–14, respectively
(P for trend = 0.005). When the 1996–1998 period was
excluded from the trend analyses, an increasing trend for
ST47 was observed with rates of 1.9%, 4.4%, and 6.5% in
2009–10, 2011–12, and 2013–14, respectively (P for trend
= 0.050).
3.2. Demographic characteristics of the patients with M.
tuberculosis strains isolated
The demographic data of the patients are summarized
in Table 2. The ratio of the age group of 15–44 years was
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Table 1. The distribution of M. tuberculosis strains’ spoligotypes according to different study years (n, %).
Clade

SIT number

2009–2014

1996–1998

Total

P*

T1

53

105 (24.9)

11 (22.4)

116 (24.7)

0.702

LAM7-TUR

41

29 (6.9)

9 (18.4)

38 (8.1)

0.011**

H3

50

24 (5.7)

3 (6.1)

27 (5.7)

0.753**

T1

284

22 (5.2)

0

22 (4.7)

0.151**

H1

47

17 (4.0)

2 (4.1)

19 (4.0)

1.000**

Unknown

4

16 (3.8)

4 (8.2)

20 (4.3)

0.144**

Beijing

1

11 (2.6)

0

11 (2.3)

0.615**

T2

52

10 (2.4)

0

10 (2.1)

0.609**

H3

262

9 (2.1)

0

9 (1.9)

0.607**

T1

7

7 (1.7)

0

7 (1.5)

1.000**

S

34

6 (1.4)

1 (2.0)

7 (1.5)

0.540**

T1

196

6 (1.4)

1 (2.0)

7 (1.5)

0.540**

LAM9

42

6 (1.4)

0

6 (1.3)

1.000**

Ambiguous LAM5 LAM4

608

2 (0.5)

2 (4.1)

4 (0.9)

NA

Other types

-

99 (23.5)

14 (28.6)

113 (24.0)

0.433

Orphan

-

52 (12.4)

2 (4.1)

54(11.5)

0.086

421 (100.0)

49 (100.0)

470 (100.0)

Total

*The results of the comparisons did not change when the orphan group (n = 54) was excluded from the analyses, **Fisher’s exact test,
NA: not available due to insufficient numbers.
Table 2. The demographic characteristics of patients with M. tuberculosis strains isolated in 2009–2014 (n, %).
Characteristic

Sex, n (%)

Total

Males

Females

246 (58.4)

175 (41.6)

421 (100.0)

0–4

0 (0)

1 (0.6)

1 (0.2)

5–14

3 (1.2)

1 (0.6)

4 (1.0)

15–24

20 (8.2)

22 (12.6)

42 (10.0)

25–34

30 (12.2)

29 (16.6)

59 (14.0)

35–44

31 (12.7)

25 (14.3)

56 (13.3)

45–54

37 (15.1)

18 (10.3)

55 (13.1)

55–64

58 (23.7)

29 (16.6)

87 (20.7)

≥65

66 (26.9)

50 (28.6)

116 (27.6)

Marmara Region

26 (10.6)

18 (10.4)

44 (10.5)

Aegean Region

117 (47.8)

95 (54.9)

212 (50.7)

Mediterranean Region

13 (5.3)

5 (2.9)

18 (4.3)

Middle Anatolia

17 (6.9)

14 (8.1)

31 (7.4)

Southeast Anatolia

7 (2.9)

10 (5.8)

17 (4.1)

Black Sea

16 (6.5)

4 (2.3)

20 (4.8)

East Anatolia

33 (13.5)

21 (12.1)

54 (12.9)

Abroad

16 (6.5)

6 (3.5)

22 (5.3)

Sex (n = 421)
Age groups (n = 420)

Birth place (n = 418)
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higher in females, while the ratio of the age group of 45–64
years was higher among males (P = 0.062, Table 2). Among
the patients, 49.6% (n = 209) were born outside of the
Aegean Region. The mean age of patients with ST53 was
significantly higher than patients with other types (Table
3). The remaining seven most common types did not show
a significant difference in mean age in comparison to the
rest of the patients. However, rare types were isolated from
significantly younger patients (Table 3).
3.3. Age groups, sex, and birth place distribution of
different spoligotypes
ST53, ST4, and ST47 were seen more frequently in older
age groups (≥45 years) while ST41, ST284, and ST1 were
more frequent in younger age groups (15–44 years). The
most predominant type among both sexes, ST53, was
followed by ST284 and ST41 in women and ST41 and
ST50 in men (Table 4). Three out of the 11 patients with
the Beijing strain isolated were born in the Middle Asian
Turkic states, while eight were born in Turkey. When
different types were compared according to birth place,
grouped as Turkey versus abroad, the Beijing strain was
significantly more frequent among patients born abroad
(13.6%, n = 3) than among patients born in Turkey (2.0%,
n = 8; P = 0.016). The distributions of different spoligotypes
according to birth place are shown in Table 3.
3.4. Infection site, microscopy positivity, drug sensitivity,
and spoligotypes
Among the 421 strains studied, 268 (63.9%) were
isolated from pulmonary TB and 131 (31.3%) from
extrapulmonary TB patients’ clinical samples, while 20
(4.8%) patients had both pulmonary and extrapulmonary
TB and the remaining two isolates were from patients with

undefined TB locations. The total pulmonary infection
rate was 68.7%. Among the extrapulmonary TB patients,
48 had TB lymphadenitis, 27 pleural TB, 19 bone/
joint/vertebra TB, eight TB peritonitis, eight skin and
subdermal tissue TB, six TB meningitis, four urinary TB,
and four TB pericarditis. The lowest pulmonary infection
rates were observed in types ST52, ST47, and ST53 and
the highest pulmonary infection rates in types ST1, ST284,
and ST50 (Table 5). The lowest pulmonary infection rates
were observed in families T (65.6%) and CAS (50%) and
the highest pulmonary infection rates in families Haarlem
(71.6%), Beijing (72.7%), and LAM (75.9%) and the
undefined strains (79.6%).
The most predominant type, ST53, was detected in
36.2% of extrapulmonary TB and 18.1% of pulmonary TB
among females, and in 18% of extrapulmonary TB and
24.9% of pulmonary TB among males. In contrast, the
second predominant type, ST41, was detected in 8.7% of
extrapulmonary TB and 4.8% of pulmonary TB among
females, and in 4.9% of extrapulmonary TB and 8.3% of
pulmonary TB among males.
Acid-fast bacilli (AFB) positivity was found in 50%
(144/288) of pulmonary TB cases and 16.8% (22/131) of
extrapulmonary cases. The lowest AFB positivity rates
among pulmonary TB cases were detected in the ST41
and ST50 spoligotypes (35%), and the highest in ST1
(75%) and ST52 (83.3%). DST was applied for 396 patients
and 14 strains showed resistance to RIF, with high-level
resistance to INH in 8, low-level resistance to INH in 20,
and multidrug resistance (MDR) in 12, of which six were
type ST1. The MDR rate was 3% (Table 5).

Table 3. Comparison of mean ages and birth places of patients with specific types compared to the rest of the patients.
Mean age (n = 421)

Birth place (n = 420)

SIT
number

Specified type

The rest of the patients

P

Aegean region

Other regions/abroad

P

53

54.3 ± 17.9

50.0 ± 20.1

0.043

61 (28.6)

44 (21.3)

0.081

41

45.9 ± 17.3

51.5 ± 19.8

0.137

12 (5.6)

17 (8.2)

0.297

50

49.3 ± 21.9

51.2 ± 19.5

0.643

10 (4.7)

14 (6.8)

0.361

284

48.6 ± 19.2

51.2 ± 19.7

0.547

14 (6.6)

8 (3.9)

0.213

47

57.2 ± 15.7

50.8 ± 19.8

0.193

12 (5.6)

5 (2.4)

0.094

4

59.6 ± 17.8

50.8 ± 19.7

0.077

9 (4.2)

7 (3.4)

0.652

1

40.0 ± 24.7

51.4 ± 19.4

0.057

1 (0.5)

10 (4.8)

0.005

52

48.8 ± 19.9

51.2 ± 19.7

0.709

4 (1.9)

6 (2.9)

0.539**

Other

50.1 ± 20.4

51.9 ± 19.0*

0.371

90 (42.3)

96 (46.4)

0.395

*The total of the most common eight types, **Fisher’s exact test.
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Table 4. The sex and age group distribution of different M. tuberculosis spoligotypes, compared to the rest of the patients (n, %).
SIT
number

Sex (n = 421)

Age groups (n = 415)**

Females

Males

P

15–44

45–64

≥65

P

P trend

53

43 (24.6)

62 (25.2)

0.883

30 (19.1)

42 (29.6)

32 (27.6)

0.086

0.085

41

11 (6.3)

18 (7.3)

0.680

16 (10.2)

9 (6.3)

4 (3.4)

0.090

0.029

50

8 (4.6)

16 (6.5)

0.399

9 (5.7)

10 (7.0)

5 (4.3)

0.645

0.671

284

12 (6.9)

10 (4.1)

0.205

9 (5.7)

8 (5.6)

5 (4.3)

0.854

0.620

47

7 (4.0)

10 (4.1)

0.973

5 (3.2)

6 (4.2)

6 (5.2)

0.712

0.410

4

8 (4.6)

8 (3.3)

0.485

2 (1.3)

6 (4.2)

8 (6.9)

0.056

0.016

1

6 (3.4)

5 (2.0)

0.537*

8 (5.1)

0 (0.0)

3 (2.6)

NA

NA

52

4 (2.3)

6 (2.4)

1.000*

3 (1.9)

5 (3.5)

2 (1.7)

NA

NA

Other

76 (43.4)

111 (45.1)

0.730

75 (47.8)

56 (39.4)

51 (44.0)

0.349

0.460

*Fisher’s exact test, **five patients <15 years old and one patient of unknown age were excluded.

Table 5. Site of infection, microscopy positivity, and drug resistance among the most common spoligotypes (n = 421).
Infected organ (n = 419)

AFB positivity (n = 417)

Pulmonary* %

Extrapulmonary %

Positive

Negative

MDR %
(n/no. of strains
with DST)

53

69 (65.7)

36 (34.3)

36 (34.3)

69 (65.7)

0.0 (0/96)

41

20 (69.0)

9 (31.0)

8 (27.6)

21 (72.4)

3.6 (1/28)

50

20 (83.3)

4 (16.7)

7 (29.2)

17 (70.8)

0.0 (0/24)

284

18 (81.8)

4 (18.2)

11 (50.0)

11 (50.0)

0.0 (0/20)

47

10 (62.5)

6 (37.5)

8 (47.1)

9 (52.9)

0.0 (0/14)

4

12 (70.6)

5 (29.4)

6 (37.5)

10 (62.5)

0.0 (0/16)

1

8 (72.7)

3 (27.3)

7 (63.6)

4 (36.4)

54.5 (6/11)

52

6 (60.0)

4 (40.0)

7 (70.0)

3 (30.0)

10.0 (1/10)

Other

125 (67.6)

60 (32.4)

76 (41.5)

107 (58.5)

2.6 (4/177)

Total

288 (68.7)

131 (31.3)

166 (39.8)

251 (60.2)

3.0 (12/396)

SIT number

*Patients having both pulmonary and extrapulmonary TB are classified as pulmonary TB cases.

4. Discussion
In Turkey, 59.5% of the new TB cases notified in 2010
were male and 40.5% were female patients (2), similar to
our study. Worldwide, TB is known to be more common
among males. Similar to the male-to-female ratio of 1.7
in European Union countries, 1.9 in other European
countries, 1.7 in high-incidence countries, 1.7 worldwide,
and 1.4 in Turkey, the male-to-female ratio of our cases
was 1.4 (1).

In our study, the 27.6% proportion of the age group
≥65 years was higher than the rates of 13.7% in Turkey
and 17.1% in İzmir, while the rate of the age group of
15–44 years (37.5%) was lower than its rate of 53.6% in
Turkey and 43.5% in İzmir (2). The high older-age ratio
could be linked to the tertiary care given at this university
hospital. The rate of women aged 15–44 years was higher
than men, while the rate of men aged 45–64 years was
higher than women. Similarly, 41.2% of female patients
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our study, similar to other studies from Turkey, we have
found that the most dominant types were ST53 and ST41,
followed by ST50 and ST284, and that ST1 is currently a
rare strain in our country.
Although different studies on multidrug-resistant TB
isolates in Turkey have found variations in the rate of the
Beijing strains between 1.3% and 50% due to differences in
their patient populations, all the studies have found very
high MDR ratios, varying from 41.3% to 66.7% among the
Beijing strains (15–17). In a study on 4069 M. tuberculosis
strains isolated in İstanbul in 2002–2005, the prevalence
of the Beijing genotype was 1.1% (46/4069), the MDR rate
was 12.5% (510/4069), the Beijing genotype’s prevalence
among multidrug-resistant TB isolates was 3.7% (19/510),
MDR was found in 41.3% (19/49) of the Beijing strains, and
10 out of the 19 Beijing strains were isolated from patients
who were citizens of former Soviet Union countries (17).
In three different studies conducted on drug-resistant
and multidrug-resistant TB isolates in Turkey, the most
common type was ST41 with rates of 26%, 22.5%, and
16.8%, and ST53 was the second most common with
rates of 14%, 19.5%, and 15.8% (15,16,18). In our study,
the rate of MDR was 3%, six of the 12 multidrug-resistant

and 36.5% of male patients were in the 15–34 age group in
Turkey in 2010 and the 45–64 age group ratio was higher
among males (30.6%) than females (24.6%). However,
no explanation can be found for TB to be relatively more
common among young women and among men aged 45–
64 years (2).
In our study, the most predominant spoligotypes
isolated among the 470 strains in 1996–2014 were ST53 with
24.7% and ST41 with 8.1%, followed by ST50, ST284, ST4,
ST47, and ST1, respectively. Several studies in Turkey have
found similar results, finding ST53 the most prevalent type
with rates differing between 27.2% and 16.1%, followed
by ST41 (8–11). However, in three different studies on
strains isolated in Ankara and East Anatolia, ST41 was
found as the most prevalent type with rates between 21%
and 47.5%, followed by ST53 (12–14). The unexpectedly
marked difference between the rates of ST53, ST41, and
ST284 in two distinct studies from Ankara may be due
to the study by Kisa et al. (11) that may represent Turkey
more reliably because of military recruitment obligations.
However, the marked difference in the ST41 ratios of two
studies from East Anatolia, namely those of Otlu et al. (10)
and Durmaz et al. (14), cannot be explained (Figure). In

This study; İzmir, 1996-2014
İzmir, 2000-2001 (8)

Black Sea Region, 2003-2005 (9)

Ankara (Middle Anatolia), 2011 (12) *
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studies (%).
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TB isolates being of the Beijing type and one being ST41.
There was no ST53 among the multidrug-resistant TB
isolates in our study. Of the Beijing strains, 54.5% (6/11)
were multidrug-resistant and two of the six Beijing strains
were isolated from former Soviet Union citizens. These
findings indicate that drug resistance is less common in
ST53, which is the dominant spoligotype in our area.
According to SITVITWEB (19), we may infer that ST53
and ST50 are common types worldwide as well, and ST41
and ST284, which are not commonly found worldwide,
may be local strains encountered mostly in Anatolia. M.
tuberculosis lineages show a strong phylogeographical
population structure, with different lineages associated
with distinct geographical regions. Lineages 1 and 3 show
a more restricted geographical distribution limited to East
Africa, India, and the shores of the Indian Ocean. The
strains of lineage 1 and lineage 3 include EAI and CAS
spoligotype clusters, respectively, and the EAI spoligotype
cluster is accepted as containing the “ancient” M.
tuberculosis strains (20). In this study, no isolate belonging
to the EAI family was found and only 0.9% (4/470) of all
isolates belonged to the CAS family. Lineage 2 includes the
Beijing family of strains and is predominant in East Asia,
but is also present in Central Asia and Russia. In this study,
2.3% (11/470) of all isolates were of the Beijing family and
three of the 11 Beijing strains were isolated from former
Soviet Union citizens. Lineage 4 includes “modern”
spoligotype families such as T, Haarlem, LAM, and X. T
is the most represented family (35%) in all of Europe and
West Asia (35.4%). Haarlem is prevalent in East Europe
and is the second most represented family in Europe
(24%). The LAM family is also prevalent in South Europe
(19). In our study, T was the most represented family
(46.6%), followed by Haarlem (16%) and LAM (12.3%).
The Anglo-Saxon ancestral X family was also very rare in
our study (0.9%).
Infection site distribution of the samples obtained
in 2009–2014 were similar to the distribution of cases
reported in Turkey in 2010 with pulmonary TB at
61.1%, extrapulmonary TB at 35.1%, and both sites at
3.8% (2). Furthermore, the male-to-female ratio found
for pulmonary TB as 2.13 and extrapulmonary TB
as 0.75 in Turkey in 2010 is in concordance with our
study’s findings of 1.74 (183/105) in pulmonary and
0.89 (62/69) in extrapulmonary TB cases (2). In studies
from different countries, extrapulmonary TB is found
to have a higher ratio among women, and despite a few
exceptions, the most common type of extrapulmonary
TB encountered is peripheral lymphadenitis; this form
is more prevalent among women than men (21–25). The
most common extrapulmonary TB forms were peripheral
lymphadenitis observed in 44.9% of women and 27.9%

of men and pleural TB found in 15.9% of women and
26.2% of men, and we have concluded that the higher
ratio of extrapulmonary TB among women is due to the
higher prevalence of peripheral lymphadenitis among
women. Different studies have found widely varying age
groups with the highest extrapulmonary TB prevalence
(21–24). In our study, similar to Turkey overall, the age
group of 45–64 years showed the lowest prevalence of
extrapulmonary TB among men (0.26%) in contrast to the
highest extrapulmonary involvement in women (1.42%).
The clustering ratio in this study was lower for
extrapulmonary TB (75.3%) than pulmonary TB (77.6%)
and the dominant spoligotypes ST53 and ST41 were more
prevalent among female extrapulmonary TB cases while
they were more prevalent in male pulmonary TB cases.
Similarly, Gonzales et al. (21) found a lower clustering
ratio in extrapulmonary TB than pulmonary TB (65%).
Although the dominant M. tuberculosis spoligotypes
show wide variation throughout different regions of the
world, the ratio of extrapulmonary TB, especially TB
lymphadenitis, is globally higher among women than
men (21,22). Although the reason for this is not clarified,
links to cellular immunity, hormones, and transmission
dynamics are postulated (23). The pulmonary infection
rates of Haarlem, Beijing, and LAM strains, with rates of
71.6%, 72.7%, and 75.9%, were in concordance with the
findings of Lari et al. (26). These rates were respectively
higher than the average infection rate (68.7%), while we
found the pulmonary infection rate of the T family (65.6%)
to be lower than the average. Although the number of
strains is very small, similar to Lari et al. (26) we also
found an association between lineage 3 (CAS) strains and
extrapulmonary disease with a rate of 50%.
Spoligotyping is the simplest technique for genotyping
of M. tuberculosis complex strains. Although spoligotyping
can be a remarkable method for molecular epidemiology
studies of M. tuberculosis, its discriminatory power is
inferior to that afforded by MIRU-VNTR and wholegenome analyses. It also cannot recognize mixed infections
and is less informative in regions with predominant or
endemic strains (27,28).
We detected a shift in the ratios of several spoligotypes
throughout the years, with decreases observed in the
ratios of ST41 and ST4 and increases observed for ST284
and ST1. Significant differences were also observed for
infection sites and AFB positivity. Pulmonary infection
and AFB positivity were higher than average in Beijing
and ST284 (one of the local, country-specific strains),
while they were lower in the ST41 spoligotype. As
pulmonary TB and AFB positivity can be considered as
factors increasing infectivity, with increasing migration
from less developed countries and from the former Soviet
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Union to Turkey, increase in the number of HIV-infected
and other immunocompromised hosts, and its increasing
trend throughout the years, the Beijing strain, with its high
MDR rate, could pose a potential threat to the tuberculosis
control program in our region. Similarly, with its higher
pulmonary involvement and AFB positivity rate, ST284
could also replace ST41 in the following years in this
region with its increasing trend.
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